| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Rose Anne Kenny | Q33304929 |
| P2093 | author name string | Brian A Lawlor | |
| Sean P Kennelly | |||
| P2860 | cites work | Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia | Q24246379 |
| Global prevalence of dementia: a Delphi consensus study | Q24603249 | ||
| Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease | Q28216782 | ||
| Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial | Q28286628 | ||
| Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group | Q28328155 | ||
| Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study | Q28366850 | ||
| A distinct role for norepinephrine in memory retrieval | Q28508141 | ||
| Nilvadipine antagonizes both Abeta vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice | Q31038586 | ||
| Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial | Q31834521 | ||
| Postural hypotension: causes, clinical features, investigation, and management | Q33144536 | ||
| Calcium alterations in Alzheimer's disease: pathophysiology, models and therapeutic opportunities | Q33540174 | ||
| Vascular protective effects of potassium. | Q33746801 | ||
| Nimodipine for primary degenerative, mixed and vascular dementia | Q33908544 | ||
| The role of cerebral ischemia in Alzheimer's disease | Q33950413 | ||
| Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus | Q34189802 | ||
| The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. | Q34331849 | ||
| Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor | Q34475374 | ||
| Alzheimer disease as a vascular disorder: nosological evidence | Q34589057 | ||
| Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression | Q35214758 | ||
| Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD. | Q35677181 | ||
| Blood pressure levels before dementia | Q36005538 | ||
| Autonomic dysfunction in dementia. | Q36226996 | ||
| Neuropathological investigation of dementia: a guide for neurologists | Q36314480 | ||
| Ageing and vascular ageing | Q36497741 | ||
| Selective vulnerability of the hippocampus in brain ischemia | Q36501847 | ||
| Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults | Q36598021 | ||
| Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation | Q40170530 | ||
| Calcium hypothesis of Alzheimer's disease and brain aging. | Q40586783 | ||
| Pharmacological treatment of hypertension | Q40624876 | ||
| Intracellular calcium changes in neuronal cells induced by Alzheimer's beta-amyloid protein are blocked by estradiol and cholesterol | Q40794411 | ||
| The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension | Q41729533 | ||
| Identification of angiotensin II receptor subtypes | Q42191856 | ||
| Association between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health Study | Q43447590 | ||
| Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia | Q43668225 | ||
| Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study | Q43935519 | ||
| The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study | Q44175666 | ||
| The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial | Q44417511 | ||
| Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease | Q44438340 | ||
| Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study | Q44949032 | ||
| Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984) | Q45071059 | ||
| Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging. | Q45176402 | ||
| Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects | Q45227720 | ||
| Midlife cardiovascular risk factors and risk of dementia in late life | Q45236740 | ||
| Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial. | Q46204112 | ||
| Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy | Q46689556 | ||
| Nilvadipine prevents cognitive decline of patients with mild cognitive impairment | Q46886049 | ||
| Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study | Q47240327 | ||
| Age‐Related Decline in Spatial Learning and Memory: Attenuation by Captopril | Q47407724 | ||
| Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD. | Q47636808 | ||
| Gene-environment interaction in Alzheimer's disease: a potential role for cholesterol | Q47680921 | ||
| Accelerated accumulation of N- and C-terminal beta APP fragments and delayed recovery of microtubule-associated protein 1B expression following stroke in aged rats. | Q47750610 | ||
| Cerebral perfusion in the elderly with nocturnal blood pressure fall. | Q48125111 | ||
| The influence of beta-blockers on delayed memory function in people with cognitive impairment | Q48153916 | ||
| Favourable effects of nilvadipine on cognitive function and regional cerebral blood flow on SPECT in hypertensive patients with mild cognitive impairment | Q48260090 | ||
| Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial | Q48359732 | ||
| Risk factors for dementia in the cardiovascular health cognition study | Q48395439 | ||
| Selective neuronal vulnerability: morphological and molecular characteristics | Q48582407 | ||
| Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study | Q49138742 | ||
| Developmental and vascular risk factors for Alzheimer's disease | Q49160928 | ||
| Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. | Q50599916 | ||
| Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older. | Q51906389 | ||
| Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population. | Q51932627 | ||
| Low blood pressure and the risk of dementia in very old individuals. | Q51944569 | ||
| Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. | Q51950626 | ||
| Relationship between blood pressure and Alzheimer's disease in Linxian County, China. | Q51951426 | ||
| Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. | Q51982382 | ||
| Postural hypotension and EEG variables predict cognitive decline: results from a 5-year follow-up of healthy elderly women. | Q52001863 | ||
| The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. | Q52013227 | ||
| Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada. | Q52019123 | ||
| Vascular risks and incident dementia: results from a cohort study of the very old. | Q53223154 | ||
| APOE genotype, plasma lipids, lipoproteins, and AD in community elderly. | Q53229960 | ||
| Midlife blood pressure and dementia: the Honolulu-Asia aging study. | Q53234678 | ||
| Expression and distribution of beta amyloid precursor protein and beta amyloid peptide in reactive astrocytes after transient middle cerebral artery occlusion. | Q53243101 | ||
| Reducing the risk of dementia: efficacy of long-term treatment of hypertension. | Q53257496 | ||
| Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan. | Q53261134 | ||
| Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. | Q53261918 | ||
| Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. | Q53276432 | ||
| Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. | Q53341397 | ||
| Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. | Q53349055 | ||
| Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. | Q53354093 | ||
| Autoregulation of cerebral blood flow in orthostatic hypotension. | Q54149037 | ||
| The mechanism of the vasodilator action of potassium. | Q54658103 | ||
| Age-Varying Association Between Blood Pressure and Risk of Dementia in Those Aged 65 and Older: A Community-Based Prospective Cohort Study | Q57318359 | ||
| Antihypertensive drugs and incidence of dementia: the Rotterdam Study | Q57782073 | ||
| Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study | Q57782154 | ||
| Long-term predictors of cognitive outcome in a cohort of older people with hypertension | Q57972067 | ||
| Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study | Q59538331 | ||
| 15-year longitudinal study of blood pressure and dementia | Q71021081 | ||
| High potassium diets reduce vascular and plasma lipid peroxides in stroke-prone spontaneously hypertensive rats | Q71469907 | ||
| Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model | Q73337645 | ||
| Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails | Q73413378 | ||
| "Mixed dementia": adequate or antiquated? A critical review | Q73860573 | ||
| Preservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African Americans | Q78358118 | ||
| Pleiotropic effects of angiotensin-converting enzyme inhibitors and the future of cachexia therapy | Q81452388 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dementia | Q83030 |
| P304 | page(s) | 241-260 | |
| P577 | publication date | 2009-07-01 | |
| P1433 | published in | Therapeutic advances in neurological disorders | Q26842039 |
| P1476 | title | Blood pressure and dementia - a comprehensive review | |
| P478 | volume | 2 |
| Q33572617 | A practical approach to the pharmacological management of hypertension in older people |
| Q90432920 | Adiponectin and Cognitive Decline |
| Q47801025 | Association Between Microinfarcts and Blood Pressure Trajectories |
| Q35917052 | Association between APOE ε4 Genotype and Memory Impairment in Elderly with Normal Global Cognitive Assessment |
| Q35649520 | Astrocyte contributions to flow/pressure-evoked parenchymal arteriole vasoconstriction |
| Q92773105 | Beta-blocker therapy and risk of vascular dementia: A population-based prospective study |
| Q37686919 | Blood Pressure and Risk of Vascular Dementia: Evidence From a Primary Care Registry and a Cohort Study of Transient Ischemic Attack and Stroke. |
| Q42617719 | Blood pressure at age 60-65 versus age 70-75 and vascular dementia: a population based observational study |
| Q38577801 | Can we influence the epidemiology of dementia? Perspectives from population-based studies |
| Q38643560 | Cardiovascular Disease, the Nitric Oxide Pathway and Risk of Cognitive Impairment and Dementia |
| Q90682016 | Characteristic changes in the default mode network in hypertensive patients with cognitive impairment |
| Q88978931 | Childhood Lead Exposure and Adult Neurodegenerative Disease |
| Q87883091 | Clinical Trials of Blood Pressure Lowering and Antihypertensive Medication: Is Cognitive Measurement State-of-the-Art? |
| Q89677247 | Combination of diabetes mellitus and lack of habitual physical activity is a risk factor for functional disability in Japanese |
| Q90387205 | Comparison of processing speed, balance, mobility and fear of falling between hypertensive and normotensive individuals |
| Q30235254 | Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review |
| Q38653373 | Dementia risk and prevention by targeting modifiable vascular risk factors. |
| Q24186820 | Dietary interventions for maintaining cognitive function in cognitively healthy people in late life |
| Q24186838 | Dietary interventions for maintaining cognitive function in cognitively healthy people in mid life |
| Q92256567 | Effects of Blood Pressure on Cognitive Performance: A Systematic Review |
| Q46202553 | Effects of occupational exposure to noise and dust on blood pressure in Chinese industrial workers |
| Q33897058 | Epidemiology of dementia in Central Africa (EPIDEMCA): protocol for a multicentre population-based study in rural and urban areas of the Central African Republic and the Republic of Congo. |
| Q30845405 | Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review |
| Q47162270 | High salt induced hypertension leads to cognitive defect. |
| Q92243195 | Hypertension and Cognitive Decline: Implications of Obstructive Sleep Apnea |
| Q35646388 | Hypertension and dementia in the elderly: the leisure world cohort study |
| Q34347981 | Hypotension and environmental noise: a replication study |
| Q31049097 | Independent and interactive impacts of hypertension and diabetes mellitus on verbal memory: A coordinated analysis of longitudinal data from England, Sweden, and the United States |
| Q91847792 | Intensive control of hypertension and risk of Alzheimer's dementia in older adults with depression |
| Q36244982 | Models and mechanisms of vascular dementia |
| Q42339163 | More accurate systolic blood pressure measurement is required for improved hypertension management: a perspective |
| Q91841423 | NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. |
| Q26738343 | Neurocardiovascular Instability and Cognition |
| Q89460111 | Neurovascular unit dysregulation, white matter disease, and executive dysfunction: the shared triad of vascular cognitive impairment and Alzheimer disease |
| Q30241411 | New horizons: the management of hypertension in people with dementia. |
| Q30235369 | Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis |
| Q92862682 | Pathways of Prevention: A Scoping Review of Dietary and Exercise Interventions for Neurocognition |
| Q40059140 | Persistence with Antihypertensive Drugs in Patients with Hypertension and Dementia in Germany |
| Q92955577 | Polygenic risk score for Alzheimer's disease and trajectories of cardiometabolic risk factors in children |
| Q89558681 | Possibilities of Dementia Prevention - It is Never Too Early to Start |
| Q57156915 | Preterm Delivery and Maternal Cardiovascular Disease Risk Factors: The Nurses' Health Study II |
| Q39035947 | Prevalence of hypotension and its association with cognitive function among older adults |
| Q92054777 | Preventing dementia by preventing stroke: The Berlin Manifesto |
| Q28080456 | Primary prevention: do the very elderly require a different approach? |
| Q59326921 | Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study |
| Q50545954 | Resting-State Cardiac Workload is Related to Both Increased Neocortical Aggregation of Amyloid-β and Relative Impairments in Spatial Working Memory in Pre-Clinical Alzheimer's Disease. |
| Q38381041 | Search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways |
| Q93185032 | Small vessel disease to subcortical dementia: a dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit |
| Q91594877 | Spotlight on hypertension in the Indian subcontinent |
| Q36825862 | The projected effect of risk factor reduction on Alzheimer's disease prevalence |
| Q36834225 | User perceptions of a dementia risk reduction website and its promotion of behavior change |
| Q36767965 | Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo |
Search more.